Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $154,868 - $232,670
2,228 New
2,228 $221,000
Q1 2023

May 01, 2023

BUY
$135.66 - $197.02 $92,384 - $134,170
681 Added 57.86%
1,858 $285,000
Q4 2022

Feb 10, 2023

BUY
$118.38 - $210.04 $139,333 - $247,217
1,177 New
1,177 $211,000
Q2 2022

Jul 27, 2022

SELL
$117.13 - $176.59 $152,854 - $230,449
-1,305 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$126.46 - $235.05 $48,307 - $89,789
382 Added 41.39%
1,305 $225,000
Q4 2021

Feb 10, 2022

BUY
$225.82 - $368.51 $23,259 - $37,956
103 Added 12.56%
923 $217,000
Q3 2021

Oct 20, 2021

SELL
$221.9 - $484.47 $22,855 - $49,900
-103 Reduced 11.16%
820 $280,000
Q2 2021

Jul 21, 2021

BUY
$129.91 - $234.98 $119,906 - $216,886
923 New
923 $217,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.